Boyer-Diaz, Zoe; Domingo, Joan Carles; De Gregorio, Estefanía; Manicardi, Nicolò; Aristu-Zabalza, Peio; Cordobilla, Begoña; Abad-Jordà, Laia; Ortega-Ribera, Martí; Fernández-Iglesias, Anabel; Marí, Montserrat; Bosch, Jaime; Gracia-Sancho, Jordi (2019). A Nutraceutical Rich in Docosahexaenoic Acid Improves Portal Hypertension in a Preclinical Model of Advanced Chronic Liver Disease. Nutrients, 11(10) Molecular Diversity Preservation International MDPI 10.3390/nu11102358
|
Text
nutrients-11-02358.pdf - Published Version Available under License Creative Commons: Attribution (CC-BY). Download (3MB) | Preview |
Inflammation and oxidative stress play a key role in the pathophysiology of advanced chronic liver disease (ACLD) and portal hypertension (PH). Considering the current lack of effective treatments, we evaluated an anti-inflammatory and antioxidant nutraceutical rich in docosahexaenoic acid (DHA) as a possible therapy for ACLD. We investigated the effects of two-week DHA supplementation (500 mg/kg) on hepatic fatty acids, PH, oxidative stress, inflammation, and hepatic stellate cell (HSC) phenotype in rats with ACLD. Additionally, the effects of DHA were evaluated in murine macrophages and human HSC. In contrast to vehicle-treated animals, cirrhotic rats receiving DHA reestablished a healthy hepatic fatty acid profile, which was associated with an improvement in PH. The mechanisms underlying this hemodynamic improvement included a reduction in oxidative stress and inflammation, as well as a marked HSC deactivation, confirmed in human HSC. Experiments with cultured macrophages showed that treatment with DHA protects against pro-inflammatory insults. The present preclinical study demonstrates that a nutraceutical rich in DHA significantly improves PH in chronic liver disease mainly by suppressing inflammation and oxidative stress-driven HSC activation, encouraging its evaluation as a new treatment for PH and cirrhosis.
Item Type: |
Journal Article (Original Article) |
|---|---|
Division/Institute: |
04 Faculty of Medicine > Pre-clinic Human Medicine > BioMedical Research (DBMR) > DBMR Forschung Mu35 > Forschungsgruppe Hepatologie 04 Faculty of Medicine > Pre-clinic Human Medicine > BioMedical Research (DBMR) > DBMR Forschung Mu35 > Forschungsgruppe Hepatologie |
UniBE Contributor: |
Bosch Genover, Jaime, Gracia Sancho, Jorge Sergio |
Subjects: |
600 Technology > 610 Medicine & health |
ISSN: |
2072-6643 |
Publisher: |
Molecular Diversity Preservation International MDPI |
Language: |
English |
Submitter: |
Thi Thao Anh Pham |
Date Deposited: |
17 Jan 2020 14:13 |
Last Modified: |
03 Apr 2024 04:05 |
Publisher DOI: |
10.3390/nu11102358 |
PubMed ID: |
31623374 |
Uncontrolled Keywords: |
DHA hepatic hemodynamics liver cirrhosis liver fibrosis omega-3 |
BORIS DOI: |
10.7892/boris.137285 |
URI: |
https://boris.unibe.ch/id/eprint/137285 |
Actions (login required)
 |
Edit item |